About Jubilant Pharma
Founded in 1978 and headquartered in Noida, India, the company operates in the pharmaceutical sector. Active pharmaceutical ingredients are produced for other firms, alongside generic and specialty drugs, including allergy therapies. Contract manufacturing is provided for parenteral products, ophthalmics, ointments, creams, and gels. Radiopharmaceuticals for nuclear medicine are specialized in, supported by a global pharmacy network. Finished dosage forms are supplied across various therapeutic areas.
- Headquarter Noida, India
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vanthys Pharmaceutical Development Private Limited
- Date of Incorporation 11 May, 2009
- Jurisdiction Noida, Uttar Pradesh, India
-
Annual Revenue
$42.31 K (USD)0.03as on Mar 31, 2018
-
Net Profit
$29.51 K (USD)8.39as on Mar 31, 2018
-
EBITDA
$-2.73 K (USD)5.94as on Mar 31, 2018
-
Latest Funding Round
$400 M (USD), Debt – Conventional
Jul 14, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Jubilant Pharma
- Total Funding Total Funding
- Total Rounds 2
- Last Round Debt – Conventional — $400.0M
-
First Round
First Round
(05 Mar 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Debt – Conventional - Jubilant Pharma | Valuation |
investors |
|
| Mar, 2019 | Amount | Debt – Conventional - Jubilant Pharma | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Jubilant Pharma
Jubilant Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Standard Chartered. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate, investment, wealth, and retail banking services are provided globally.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Jubilant Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Jubilant Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Jubilant Pharma Comparisons
Competitors of Jubilant Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Jubilant Pharma
Frequently Asked Questions about Jubilant Pharma
When was Jubilant Pharma founded?
Jubilant Pharma was founded in 1978 and raised its 1st funding round 41 years after it was founded.
Where is Jubilant Pharma located?
Jubilant Pharma is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
What is the annual revenue of Jubilant Pharma?
Annual revenue of Jubilant Pharma is $42.31K as on Mar 31, 2018.
What does Jubilant Pharma do?
Founded in 1978 and headquartered in Noida, India, the company operates in the pharmaceutical sector. Active pharmaceutical ingredients are produced for other firms, alongside generic and specialty drugs, including allergy therapies. Contract manufacturing is provided for parenteral products, ophthalmics, ointments, creams, and gels. Radiopharmaceuticals for nuclear medicine are specialized in, supported by a global pharmacy network. Finished dosage forms are supplied across various therapeutic areas.
Who are Jubilant Pharma's investors?
Jubilant Pharma has 1 investor. Key investors include Standard Chartered.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.